The global RNA interference (RNAi) drug delivery market was worth $7 billion in 2010 and is expected to grow to nearly $24.1 billion by 2015 at a 5-year compound annual growth rate (CAGR) of 27.9%.
Learn about the latest trends in RNAi therapeutics, with focus on the main areas of clinical need, general/proprietary technologies and company pipelines, and the activities and strategies of RNAi-based developers. This report also provides forecasts for market growth to 2015 across major RNAi market segments…
Use this report to:
- Learn about emerging RNAi molecules and delivery technologies as well as new molecular targets and pipeline drugs
- Assess important trends in technology development for RNAi in major therapeutic areas and licensing opportunities for novel delivery platforms
- Evaluate the commercial potential of emerging therapeutics and delivery technologies based on crucial statistics and analysis of the market structure, market size, and key drug segments
- Incorporate analysis of competitors and collaborators in developing RNAi technologies, the market shares of key players and drugs, and the latest RNAi-related patenting trends into your business strategy.
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.